Veracyte Funding & Investors
Veracyte, Inc. develops molecular tests for oncology. The Company offers molecular cytology and tests for the diagnostic accuracy of cytology samples. Veracyte provides its products and services to healthcare and molecular diagnostic companies in the United States.
https://www.veracyte.com/Total Amount Raised: $681,249,984
Veracyte Funding Rounds
Post Ipo Equity
$550,000,000
Post Ipo Debt
$45,000,000
Post Ipo Debt Investors
Visium Healthcare PartnersDebt Financing
$15,000,000
Debt Financing Investors
Armentum PartnersSeries C
$28,000,000
Series C Investors
Versant VenturesGE VenturesKleiner Perkins Caufield & ByersTPG BiotechDomain AssociatesSeries Unknown
$14,950,000
Series Unknown Investors
Kleiner Perkins Caufield & ByersDomain AssociatesSeries B
$28,000,000
Series B Investors
Versant VenturesTPG BiotechKleiner Perkins Caufield & ByersDomain AssociatesSeries A
$300,000
Funding info provided by Diffbot.